Connect with us

Published

on

Jensen Huang, co-founder and chief executive officer of Nvidia Corp., during the Nvidia GPU Technology Conference (GTC) in San Jose, California, US, on Tuesday, March 19, 2024. 

David Paul Morris | Bloomberg | Getty Images

Nvidia’s 27% rally in May pushed its market cap to $2.7 trillion, behind only Microsoft and Apple among the most-valuable public companies in the world. The chipmaker reported a tripling in year-over-year sales for the third straight quarter driven by soaring demand for its artificial intelligence processors.

Mizuho Securities estimates that Nvidia controls between 70% and 95% of the market for AI chips used for training and deploying models like OpenAI’s GPT. Underscoring Nvidia’s pricing power is a 78% gross margin, a stunningly high number for a hardware company that has to manufacture and ship physical products.

Rival chipmakers Intel and Advanced Micro Devices reported gross margins in the latest quarter of 41% and 47%, respectively.

Nvidia’s position in the AI chip market has been described as a moat by some experts. Its flagship AI graphics processing units (GPUs), such as the H100, coupled with the company’s CUDA software led to such a head start on the competition that switching to an alternative can seem almost unthinkable.

Still, Nvidia CEO Jensen Huang, whose net worth has swelled from $3 billion to about $90 billion in the past five years, has said he’s “worried and concerned” about his 31-year-old company losing its edge. He acknowledged at a conference late last year that there are many powerful competitors on the rise.

“I don’t think people are trying to put me out of business,” Huang said in November. “I probably know they’re trying to, so that’s different.”

Nvidia has committed to releasing a new AI chip architecture every year, rather than every other year as was the case historically, and to putting out new software that could more deeply entrench its chips in AI software.

But Nvidia’s GPU isn’t alone in being able to run the complex math that underpins generative AI. If less powerful chips can do the same work, Huang might be justifiably paranoid.

The transition from training AI models to what’s called inference — or deploying the models — could also give companies an opportunity to replace Nvidia’s GPUs, especially if they’re less expensive to buy and run. Nvidia’s flagship chip costs roughly $30,000 or more, giving customers plenty of incentive to seek alternatives.

“Nvidia would love to have 100% of it, but customers would not love for Nvidia to have 100% of it,” said Sid Sheth, co-founder of aspiring rival D-Matrix. “It’s just too big of an opportunity. It would be too unhealthy if any one company took all of it.”

Founded in 2019, D-Matrix plans to release a semiconductor card for servers later this year that aims to reduce the cost and latency of running AI models. The company raised $110 million in September.

In addition to D-Matrix, companies ranging from multinational corporations to nascent startups are fighting for a slice of the AI chip market that could reach $400 billion in annual sales in the next five years, according to market analysts and AMD. Nvidia has generated about $80 billion in revenue over the past four quarters, and Bank of America estimates the company sold $34.5 billion in AI chips last year.

Many companies taking on Nvidia’s GPUs are betting that a different architecture or certain trade-offs could produce a better chip for particular tasks. Device makers are also developing technology that could end up doing a lot of the computing for AI that’s currently taking place in large GPU-based clusters in the cloud.

“Nobody can deny that today Nvidia is the hardware you want to train and run AI models,” Fernando Vidal, co-founder of 3Fourteen Research, told CNBC. “But there’s been incremental progress in leveling the playing field, from hyperscalers working on their own chips, to even little startups, designing their own silicon.”

AMD CEO Lisa Su wants investors to believe there’s plenty of room for many successful companies in the space.

“The key is that there are a lot of options there,” Su told reporters in December, when her company launched its most recent AI chip. “I think we’re going to see a situation where there’s not only one solution, there will be multiple solutions.”

Other big chipmakers

Lisa Su displays an AMD Instinct MI300 chip as she delivers a keynote address at CES 2023 in Las Vegas, Nevada, on Jan. 4, 2023.

David Becker | Getty Images

Nvidia’s top customers

How AWS is designing its own chips to help catch Microsoft and Google in generative A.I. race

One potential challenge for Nvidia is that it’s competing against some of its biggest customers. Cloud providers including Google, Microsoft and Amazon are all building processors for internal use. The Big Tech three, plus Oracle, make up over 40% of Nvidia’s revenue.

Amazon introduced its own AI-oriented chips in 2018, under the Inferentia brand name. Inferentia is now on its second version. In 2021, Amazon Web Services debuted Tranium targeted to training. Customers can’t buy the chips but they can rent systems through AWS, which markets the chips as more cost efficient than Nvidia’s.

Google is perhaps the cloud provider most committed to its own silicon. The company has been using what it calls Tensor Processing Units (TPUs) since 2015 to train and deploy AI models. In May, Google announced the sixth version of its chip, Trillium, which the company said was used to develop its models, including Gemini and Imagen.

Google also uses Nvidia chips and offers them through its cloud.

Microsoft isn’t as far along. The company said last year that it was building its own AI accelerator and processor, called Maia and Cobalt.

Meta isn’t a cloud provider, but the company needs massive amounts of computing power to run its software and website and to serve ads. While the Facebook parent company is buying billions of dollars worth of Nvidia processors, it said in April that some of its homegrown chips were already in data centers and enabled “greater efficiency” compared to GPUs.

JPMorgan analysts estimated in May that the market for building custom chips for big cloud providers could be worth as much as $30 billion, with potential growth of 20% per year.

Startups

Cerebras’ WSE-3 chip is one example of new silicon from upstarts designed to run and train artificial intelligence.

Cerebras Systems

Venture capitalists see opportunities for emerging companies to jump into the game. They invested $6 billion in AI semiconductor companies in 2023, up slightly from $5.7 billion a year earlier, according to data from PitchBook.

It’s a tough area for startups as semiconductors are expensive to design, develop and manufacture. But there are opportunities for differentiation.

For Cerebras Systems, an AI chipmaker in Silicon Valley, the focus is on basic operations and bottlenecks for AI, versus the more general purpose nature of a GPU. The company was founded in 2015 and was valued at $4 billion during its most recent fundraising, according to Bloomberg.

The Cerebras chip, WSE-2, puts GPU capabilities as well as central processing and additional memory into a single device, which is better for training large models, said CEO Andrew Feldman.

“We use a giant chip, they use a lot of little chips,” Feldman said. “They’ve got challenges of moving data around, we don’t.”

Feldman said his company, which counts Mayo Clinic, GlaxoSmithKline, and the U.S. Military as clients, is winning business for its supercomputing systems even going up against Nvidia.

“There’s ample competition and I think that’s healthy for the ecosystem,” Feldman said.

Sheth from D-Matrix said his company plans to release a card with its chiplet later this year that will allow for more computation in memory, as opposed to on a chip like a GPU. D-Matrix’s product can be slotted into an AI server along existing GPUs, but it takes work off of Nvidia chips, and helps to lower the cost of generative AI.

Customers “are very receptive and very incentivized to enable a new solution to come to market,” Sheth said.

Apple and Qualcomm

Apple iPhone 15 series devices are displayed for sale at The Grove Apple retail store on release day in Los Angeles, California, on September 22, 2023. 

Patrick T. Fallon | Afp | Getty Images

Don’t miss these exclusives from CNBC PRO

Nvidia and Microsoft has overshadowed weakness in tech stocks, says Solus' Dan Greenhaus

Continue Reading

Technology

Shares in Chinese chipmaker SMIC drop nearly 7% after earnings miss

Published

on

By

 Shares in Chinese chipmaker SMIC drop nearly 7% after earnings miss

A logo hangs on the building of the Beijing branch of Semiconductor Manufacturing International Corporation (SMIC) on December 4, 2020 in Beijing, China.

Vcg | Visual China Group | Getty Images

Shares of Semiconductor Manufacturing International Corporation, China’s largest contract chip maker, fell nearly 7% Friday after its first-quarter earnings missed estimates.

After trading on Thursday, the company reported a first-quarter revenue of $2.24 billion, up about 28% from a year earlier. Meanwhile, profit attributable to shareholders surged 162% year on year to $188 million.

However, both figures missed LSEG mean estimates of $2.34 billion in revenue and $225.1 million in net income, as well as the company’s own forecasts.

During an earnings call Friday, an SMIC representative said the earnings missed original guidance due to “production fluctuations” which sent blended average selling prices falling. This impact is expected to extend into the second quarter, they added.

For the current quarter, the chipmaker forecasted revenue to fall 4% to 6% sequentially. Gross margin is also expected to fall within the range of 18% to 20%, compared to 22.5% in the first quarter.

Still, the first quarter saw SMIC’s wafer shipments increase by 15% from the previous quarter and by about 28% year-on-year.

In the earnings call, SMIC attributed that growth to customer shipment pull in, brought by changes in geopolitics and increased demand driven by government policies such as domestic trade-in programs and consumption subsidies.

In another positive sign for the company, its first-quarter capacity utilization— the percentage of total available manufacturing capacity that is being used at any given time— reached 89.6%, up 4.1% quarter on quarter.

Demand in China for chips is extremely strong, says Benchmark's Cody Acree

“SMIC’s nearly 90% utilization rate reflects strong domestic demand for semiconductors, likely driven by smartphone and consumer electronics production,” said Ray Wang, a Washington-based semiconductor and technology analyst, adding that the demand was also reflected in the company’s strong quarterly revenue growth.

Meanwhile, the company said in the earnings call that it is “currently in an important period of capacity construction, roll out, and continuously increasing market share.”

However, SMIC’s first-quarter research and development spending decreased to $148.9 million, down from $217 million in the previous quarter.

Amid increased demand, it will be crucial for SMIC to continue ramping up their capacity, Simon Chen, principal analyst of semiconductor manufacturing at Informa Tech told CNBC.

SMIC generates most of its revenue from older-generation semiconductors, often referred to as “mature-node” or “legacy” chips, which are commonly found in consumer electronics and industrial equipment.

The state-backed chipmaker is critical to Beijing’s ambitions to build a self-sufficient semiconductor supply chain, with the government pumping billions into such efforts. Over 84% of its first-quarter revenue was derived from customers in China.

“The localization transformation of the supply chain has been strengthened, and more manufacturing demand has shifted back domestically,” a representative said Friday.

However, chip analysts say the chipmaker’s ability to increase capacity in advance chips — used in applications that demand higher levels of computing performance and efficiency at higher yields — is limited.

This is due to U.S.-led export controls, which prevent it from accessing some of the world’s most advanced chip-making equipment from the Netherlands-based ASML. 

Nevertheless, the chipmaker appears to be making some breakthroughs. Advanced chips manufactured by SMIC have reportedly appeared in various Huawei products, notably in the Mate 60 Pro smartphone and some AI processors.

In the earnings call, the company also said it would closely monitor the potential impacts of the U.S.-China trade war on its demand, noting a lack of visibility for the second half of the year.

Phelix Lee, an equity analyst for Morningstar focused on semiconductors, told CNBC that the impacts of U.S. tariffs on SMIC are limited due to most of its revenue coming from Chinese customers.

While U.S. customers make up about 8-15% of revenue on a quarterly basis, the chips usually remain and are consumed in Chinese products and end users, he said.

“There could be some disruption to chemical, gas, and equipment supply; but the firm is working on alternatives in China and other non-U.S. regions,” he added.

SMIC’s Hong Kong-listed shares have gained over 32.23% year-to-date.

Continue Reading

Technology

Amazon adds pet prescriptions to its online pharmacy

Published

on

By

Amazon adds pet prescriptions to its online pharmacy

Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021. 

Smith Collection | Gado | Getty Images

Amazon is expanding its online pharmacy to fill prescription pet medications, the company announced Thursday.

The company said it has added “hundreds of commonly prescribed pet medications” to its U.S. site, ranging from flea and tick solutions to treatments for chronic conditions.

Prescriptions are purchased via Amazon’s storefront and must be approved by a veterinarian. Online pet pharmacy Vetsource will oversee the dispensing and delivery of medications, said Amazon, adding that items are typically delivered within two to six days.

Amazon launched its digital drugstore in 2020 with the added perk of discounts and free delivery for Prime members. The company has been working to speed up prescription shipments over the past year, bringing same-day delivery to a handful of U.S. cities. Last October, Amazon set a goal to make speedy medicine delivery available in nearly half of the U.S. in 2025.

The new pet medication offerings puts Amazon into more direct competition with online pet pharmacy Chewy, as well as Walmart, which offers pet prescription delivery.

Amazon Pharmacy is part of the company’s growing stable of healthcare offerings, which also includes One Medical, the primary care provider it acquired for roughly $3.9 billion in July 2022. Amazon’s online pharmacy was born out of the company’s 2018 acquisition of online pharmacy PillPack.

WATCH: Amazon’s new Vulcan robot can ‘feel’ what it touches

Here's a first look at Vulcan, Amazon's new stowing robot that can feel what it touches

Continue Reading

Technology

Coinbase acquires crypto derivatives exchange Deribit for $2.9 billion

Published

on

By

Coinbase acquires crypto derivatives exchange Deribit for .9 billion

The Coinbase logo is displayed on a smartphone with stock market percentages on the background.

Omar Marques | SOPA Images | Lightrocket | Getty Images

Coinbase agreed to acquire Dubai-based Deribit, a major crypto derivatives exchange, for $2.9 billion, the largest deal in the crypto industry to date.

The company said Thursday that the cost comprises $700 million in cash and 11 million shares of Coinbase class A common stock. The transaction is expected to close by the end of the year.

Shares of Coinbase rose nearly 6%.

The acquisition positions Coinbase as an international leader in crypto derivatives by open interest and options volume, Greg Tusar, vice president of institutional product, said in a blog post – which could allow it take on big players like Binance. Coinbase operates the largest marketplace for buying and selling cryptocurrencies within the U.S., but has a smaller share of the global crypto market, where activity largely takes place on Binance.

Deribit facilitated more than $1 trillion in trading volume last year and has about $30 billion of current open interest on the platform.

“We’re excited to join forces with Coinbase to power a new era in global crypto derivatives,” Deribit CEO Luuk Strijers said in a statement. “As the leading crypto options platform, we’ve built a strong, profitable business, and this acquisition will accelerate the foundation we laid while providing traders with even more opportunities across spot, futures, perpetuals, and options – all under one trusted brand. Together with Coinbase, we’re set to shape the future of the global crypto derivatives market.”

Tusar also noted that Deribit has a “consistent track record” of generating positive adjusted EBITDA the company believes will grow as a combined entity.  

“One of the things we liked most about this deal is that it’s not just a game changer for our international expansion plans — it immediately diversifies our revenue and enhances profitability,” Tusar told CNBC.

The deal comes at a time when the crypto industry is riding regulatory tailwinds from the first ever pro-crypto White House. Support of the industry has fueled crypto M&A activity in recent weeks. In March, crypto exchange Kraken agreed to acquire NinjaTrader for $1.5 billion, and last month Ripple agreed to buy prime broker Hidden Road.

Don’t miss these cryptocurrency insights from CNBC Pro:

Continue Reading

Trending